Company: BIAF
Filing Date: 2025-09-17
Form Type: 8-K
Source: 0001493152-25-013892
Chunk: 3

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-17
Form: 8-K
Item: Item 7.01
Chunk 3
---
Item
7.01 Regulation FD Disclosure

On September 17, 2025, the
Company issued a press release announcing the Reverse Stock Split. A copy of the press release
is furnished to this Current Report on Form 8-K as Exhibit 99.1.

The
information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is furnished and shall not be deemed to be “filed”
for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject
to the liabilities of that section. The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be
incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after
the date of this Current Report, regardless of any general incorporation language in any such filing.

Item
9.01 Financial Statements and Exhibits